Recently, the Trump Administration announced plans to initiate a new Section 301 investigation into foreign drug pricing policies, which it…
Aimed Alliance recently sent a letter to the California legislature urging for the ban of copay accumulator programs. These programs…
On August, 28, 2024, Aimed Alliance received an interim response from the Food and Drug Administration regarding its Citizen Petition on…
Aimed Alliance sent letters to the Maryland PDAB urging it to proceed cautiously with setting a UPL for Jardiance and…
For decades, rising costs of health care, health insurance, and prescription drugs have been a major concern for American consumers, caregivers,…
Aimed Alliance recently sent a letter urging the Virginia House Labor and Commerce Committee to reconsider House Bill 483, which…
Aimed Alliance is pleased to share two new resources on prescription drug affordability boards (PDABs). PDABs are established at the…
Gold card laws exempt healthcare providers from prior authorization if they have a high approval rate, reducing delays in patient…
Aimed Alliance, the National Bleeding Disorders Foundation and the Hemophilia Alliance, released a new resource, “Protecting Consumers from Unfair and…
On December 5, 2025, Aimed Alliance’s Counsel, Michael Barnes, published a new opinion piece titled “Trump Administration Took Decisive Action…